Ecosse

What Ecosse does

Ecosse Medical Communications, LLC is a privately held medical communications agency headquartered in Falmouth, Massachusetts (registered in the USA), founded by David Norris PhD around 2000. The company provides specialized scientific content development, regulatory writing, and strategic consulting services to biotechnology and pharmaceutical companies. Its service portfolio is organized into three pillars: Content Development (clinical manuscripts, review articles, scientific posters, PowerPoint presentations, meeting abstracts, journal supplements, formulary kits, scientific and medical monographs, white papers, newsletters, meeting reporters, and web content), Regulatory Writing (clinical study reports, integrated summaries of efficacy, clinical protocols, and integrated summaries of safety), and Consulting (publication planning, marketing team training, clinical and marketing messaging, and competitive intelligence). In-house graphic art capabilities support visual deliverables across print, slide, and web formats.

The company differentiates through the academic credentials and therapeutic expertise of its founders rather than through proprietary technology. Principal David Norris holds a PhD in Biochemistry and Molecular Pharmacology from Harvard University with postdoctoral training at Dana-Farber Cancer Institute and prior faculty service at Rutgers University; Director Linda White holds an MS in Health Care Policy and Management from Harvard School of Public Health. Ecosse does not develop software products, AI tooling, or technology platforms; its offering is human-delivered professional services. Its displayed client roster of approximately 19 organizations includes major pharmaceutical companies (AstraZeneca, Eli Lilly, Hoffmann-LaRoche, Sanofi Pasteur, Novo Nordisk, Genentech, Baxter Healthcare, Colgate-Palmolive, Otsuka America), mid-market and start-up biotechnology firms (Alkermes, Amylin, Anesiva, AngioChem, Concert Pharmaceuticals, Idenix, Medivation, MethylGene, Momenta), and the Robert Wood Johnson Foundation.

Ecosse operates a sales-led, B2B professional services business model with 11-50 employees. Revenue is generated on a project basis with quote-based or project-based pricing that is not publicly disclosed. Client acquisition is driven by direct outreach and referrals rather than digital marketing, with the website serving as the primary content marketing asset. No external investors, parent company, or M&A activity is disclosed; the firm operates as a founder-controlled boutique consultancy with no proprietary technology or AI/ML capabilities documented in the source material.

Name

Ecosse

Legal name

Ecosse Medical Communications, LLC

Website

https://ecosse-med.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Ecosse Medical Communications is a private medical communications agency providing content development, regulatory writing, and consulting services to biotechnology and pharmaceutical companies across multiple therapeutic areas.

Ownership category

akta.pro rank

Product category

Medical Communications Services

akta.pro primary industry

Medical Affairs Scientific Communications (MSL Support/Scientific Response) (HLAGALAF)

akta.pro secondary industries

Medical Writing & Clinical Documentation FSP (HLAGAOAC), Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN)

Keywords

• Medical communications
• Regulatory writing
• Scientific content development
• Pharmaceutical publications
• Medical writing services

Headquarters

HQ city

Maussane

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Communications Services: Ecosse generates revenue through providing specialized medical and scientific communications services to the biotechnology and pharmaceutical industries. Services include content development (clinical manuscripts, review articles, scientific posters, PowerPoint presentations, newsletters, web content), regulatory writing (clinical study reports, clinical protocols, integrated summaries of efficacy and safety), and consulting services (publication planning, marketing team training, clinical/marketing messaging, competitive intelligence). Revenue is derived from professional services billed to pharmaceutical and biotech clients on a project basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Ecosse Medical Communications is a specialized medical communications agency that provides high-level content development, regulatory writing, consulting, and graphic art services for the biotechnology and pharmaceutical industries. The firm supports clients from large pharmaceutical companies to biotech startups and foundations, producing scientific publications and regulatory documentation.

Product overview

Ecosse Medical Communications is a medical communications agency providing a unified suite of services for the biotechnology and pharmaceutical industries. The company operates three interconnected service pillars: Content Development Services (covering clinical manuscripts, scientific posters, presentations, white papers, monographs, and web content), Regulatory Writing Services (encompassing clinical study reports, protocols, and integrated summaries of safety and efficacy), and Consulting Services (including publication planning, marketing team training, messaging, and competitive intelligence). All services are supported by high-quality graphic art capabilities to ensure professional presentation across print, slide, and web formats. The company specializes in promotional, regulatory, and CME (Continuing Medical Education) settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Content Development Services
• Regulatory Writing Services
• Consulting Services
• Graphic Art Services

Named customers19 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Direct peers

• Nucleus Global: Network of medical communications agencies providing scientific content, publications, and strategic services to pharma. Directly comparable in service scope to Ecosse, with similar specialty-focus orientation.
• MedThink Communications: Medical affairs and scientific communications agency focused on publications planning and content for pharma/biotech. Comparable specialty MedComms focus to Ecosse.
• ApotheCom (now part of Inizio): Medical communications agency providing scientific content, publications, and strategic medical affairs services to pharma. Directly comparable service set to Ecosse across therapeutic specialty work.
• Cactus Life Sciences: Global medical communications and scientific content agency serving pharma and biotech with manuscript, regulatory, and digital offerings. Highly comparable service mix and customer base to Ecosse, at larger scale.
• Peloton Advantage: Medical communications and consulting firm providing medical affairs, publications, and scientific content services. Direct competitor for the same biotech and mid-pharma client profile.
• Complete Healthcare Communications (CHC): Specialty medical communications and publications agency serving pharma and biotech with content, regulatory writing, and medical education. Closely overlapping service catalog to Ecosse.

Broad incumbents

• Real Chemistry (formerly W2O Group): Healthcare marketing and communications group offering scientific content, PR, and data-driven engagement for life sciences. Comparable in serving pharma/biotech communications needs though a broader, larger portfolio.
• Ashfield Health / Inizio Medical: Global medical communications and consulting platform within Inizio, serving pharma with medical affairs, publications, and omnichannel content. Comparable offerings to Ecosse at significantly larger scale.
• Envision Pharma Group: Established medical communications and publications management firm serving global pharma. Overlaps Ecosse's publication planning, scientific content, and stakeholder engagement offerings but operates at materially larger scale.

Emerging players

• ProHealth Communications: Specialty medical communications firm providing scientific content, publications, and strategic medical affairs support to emerging biotech. Smaller-scale peer competing in similar niche segments.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ecosse